Indeed, GWAS studies have demonstrated that CX3CR1+ polymorphisms are associated with different CD phenotypes as well as a reduced IgG ASCA positivity, highlighting their combined importance in IBD and fungal immunity [114,117]. Here, CX3CR1 is linked to inflammatory bowel disease.